Works by Naito, Yoichi
Results: 78
D2-40-positive solitary fibrous tumors of the pleura: Diagnostic pitfall of biopsy specimen.
- Published in:
- Pathology International, 2007, v. 57, n. 9, p. 618, doi. 10.1111/j.1440-1827.2007.02148.x
- By:
- Publication type:
- Article
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 4, p. 310, doi. 10.1111/ajco.12017
- By:
- Publication type:
- Article
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2245081, doi. 10.1001/jamanetworkopen.2022.45081
- By:
- Publication type:
- Article
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 105, doi. 10.1093/jjco/hyac168
- By:
- Publication type:
- Article
Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 938, doi. 10.1093/jjco/hyz096
- By:
- Publication type:
- Article
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 6, p. 559, doi. 10.1093/jjco/hyy052
- By:
- Publication type:
- Article
Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 2, p. 137, doi. 10.1093/jjco/hyw175
- By:
- Publication type:
- Article
PD‐1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.6980
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 11, p. 12095, doi. 10.1002/cam4.5898
- By:
- Publication type:
- Article
Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 19, p. 6579, doi. 10.1002/cam4.4110
- By:
- Publication type:
- Article
A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide
- Published in:
- Cancer Medicine, 2020, v. 9, n. 10, p. 3319, doi. 10.1002/cam4.2979
- By:
- Publication type:
- Article
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 877, doi. 10.20892/j.issn.2095-3941.2020.0418
- By:
- Publication type:
- Article
Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 11, p. 922, doi. 10.1111/iju.13776
- By:
- Publication type:
- Article
Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.
- Published in:
- Case Reports in Oncological Medicine, 2020, p. 1, doi. 10.1155/2020/7231358
- By:
- Publication type:
- Article
One-year incidence of chemotherapy-induced peripheral neuropathy in oxaliplatin- or taxane-based chemotherapy: a multicenter, prospective registry study (MiroCIP study).
- Published in:
- Expert Opinion on Pharmacotherapy, 2025, v. 26, n. 3, p. 335, doi. 10.1080/14656566.2025.2455445
- By:
- Publication type:
- Article
Predominant Infiltration of Macrophages and CD8[sup+] T Cells in Cancer Nests Is a Significant Predictor of Survival in Stage IV Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 6, p. 1387, doi. 10.1002/cncr.23712
- By:
- Publication type:
- Article
Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series.
- Published in:
- IJU Case Reports, 2019, v. 2, n. 3, p. 150, doi. 10.1002/iju5.12066
- By:
- Publication type:
- Article
Gastric mesenchymal tumor with smooth muscle differentiation and echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma kinase (EML4‐ALK) fusion.
- Published in:
- Pathology International, 2021, v. 71, n. 10, p. 707, doi. 10.1111/pin.13154
- By:
- Publication type:
- Article
Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib.
- Published in:
- Clinical Medicine: Therapeutics, 2009, n. 1, p. 1027, doi. 10.4137/CMT.S2122
- By:
- Publication type:
- Article
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 3, p. 339, doi. 10.1007/s10120-023-01381-6
- By:
- Publication type:
- Article
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 118, doi. 10.1007/s10120-019-00966-4
- By:
- Publication type:
- Article
Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 2, p. 1041, doi. 10.21873/invivo.12348
- By:
- Publication type:
- Article
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11560-4
- By:
- Publication type:
- Article
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 202, n. 3, p. 473, doi. 10.1007/s10549-023-07097-6
- By:
- Publication type:
- Article
Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?
- Published in:
- International Journal of Clinical Oncology, 2007, v. 12, n. 3, p. 231, doi. 10.1007/s10147-006-0643-9
- By:
- Publication type:
- Article
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 595, doi. 10.1007/s00432-012-1349-1
- By:
- Publication type:
- Article
Circulating Tumor DNA in Oncology.
- Published in:
- Processes, 2021, v. 9, n. 12, p. 2198, doi. 10.3390/pr9122198
- By:
- Publication type:
- Article
Elderly Breast Cancer Therapy: A Japanese Experience.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 8, p. 717, doi. 10.1093/jjco/hyq061
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1568, doi. 10.1007/s10637-021-01120-7
- By:
- Publication type:
- Article
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1559, doi. 10.1007/s10637-021-01107-4
- By:
- Publication type:
- Article
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 469, doi. 10.1007/s10637-020-01001-5
- By:
- Publication type:
- Article
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
- By:
- Publication type:
- Article
A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 307, doi. 10.1007/s10637-016-0422-z
- By:
- Publication type:
- Article
Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 119, doi. 10.1007/s10637-014-0161-y
- By:
- Publication type:
- Article
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of Ado‐Trastuzumab Emtansine and Fam‐Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 635, doi. 10.1002/onco.13715
- By:
- Publication type:
- Article
Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e686, doi. 10.1002/onco.13640
- By:
- Publication type:
- Article
Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3158, doi. 10.3390/cancers13133158
- By:
- Publication type:
- Article
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2348, doi. 10.1002/cncr.34788
- By:
- Publication type:
- Article
Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors.
- Published in:
- Cancer Science, 2024, v. 115, n. 3, p. 894, doi. 10.1111/cas.16058
- By:
- Publication type:
- Article
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2023, v. 114, n. 2, p. 574, doi. 10.1111/cas.15486
- By:
- Publication type:
- Article
Chronological improvement in precision oncology implementation in Japan.
- Published in:
- Cancer Science, 2022, v. 113, n. 11, p. 3995, doi. 10.1111/cas.15517
- By:
- Publication type:
- Article
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
- Published in:
- Cancer Science, 2022, v. 113, n. 11, p. 3646, doi. 10.1111/cas.15504
- By:
- Publication type:
- Article
A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1010, doi. 10.1111/cas.15231
- By:
- Publication type:
- Article
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3911, doi. 10.1111/cas.15022
- By:
- Publication type:
- Article
Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 725, doi. 10.1111/cas.14678
- By:
- Publication type:
- Article
Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 549, doi. 10.1007/s10549-019-05318-5
- By:
- Publication type:
- Article